JP2023536633A5 - - Google Patents
Info
- Publication number
- JP2023536633A5 JP2023536633A5 JP2023507667A JP2023507667A JP2023536633A5 JP 2023536633 A5 JP2023536633 A5 JP 2023536633A5 JP 2023507667 A JP2023507667 A JP 2023507667A JP 2023507667 A JP2023507667 A JP 2023507667A JP 2023536633 A5 JP2023536633 A5 JP 2023536633A5
- Authority
- JP
- Japan
- Prior art keywords
- heteroalkyl
- alkyl
- compound
- halogen
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063060968P | 2020-08-04 | 2020-08-04 | |
| US63/060,968 | 2020-08-04 | ||
| PCT/US2021/044564 WO2022031862A2 (en) | 2020-08-04 | 2021-08-04 | Heteroaryl and heterocyclyl compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536633A JP2023536633A (ja) | 2023-08-28 |
| JP2023536633A5 true JP2023536633A5 (cg-RX-API-DMAC10.html) | 2024-08-14 |
Family
ID=80120142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507667A Pending JP2023536633A (ja) | 2020-08-04 | 2021-08-04 | ヘテロアリール及びヘテロシクリル化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230303502A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4192468A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023536633A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230048523A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116322777A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021321433A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112023002132A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3190778A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022031862A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4531879A1 (en) | 2022-05-25 | 2025-04-09 | Flagship Pioneering Innovations VI, LLC | Compositions of secretory and/or catalytic cells and methods using the same |
| JP2025520113A (ja) | 2022-06-03 | 2025-07-01 | フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー | 組成物及び方法 |
| IL328729A (en) | 2023-12-01 | 2026-07-01 | Sigilon Therapeutics Inc | Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2411197A (en) * | 1996-04-30 | 1997-11-19 | Affymax Technologies N.V. | Methods for the synthesis of fmoc protected amines |
| CN103819403B (zh) * | 2008-12-31 | 2017-01-04 | 阿德利克斯公司 | 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法 |
| ES3036749T3 (en) * | 2014-08-01 | 2025-09-23 | Massachusetts Inst Technology | Modified alginates for anti-fibrotic materials and applications |
| EP3215519A1 (en) * | 2014-11-06 | 2017-09-13 | Novartis AG | Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase |
| US20180185368A1 (en) * | 2014-11-06 | 2018-07-05 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
| CR20180229A (es) * | 2015-10-29 | 2018-08-24 | Novartis Ag | Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll |
| KR20230156818A (ko) * | 2016-10-03 | 2023-11-14 | 시질론 테라퓨틱스, 인크. | 화합물, 장치, 및 이의 용도 |
| IL315310A (en) * | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
| CN112203646A (zh) * | 2018-04-04 | 2021-01-08 | 西吉隆医疗股份有限公司 | 可植入颗粒和相关方法 |
-
2021
- 2021-08-04 CA CA3190778A patent/CA3190778A1/en active Pending
- 2021-08-04 US US18/019,664 patent/US20230303502A1/en active Pending
- 2021-08-04 BR BR112023002132A patent/BR112023002132A2/pt unknown
- 2021-08-04 CN CN202180068241.8A patent/CN116322777A/zh active Pending
- 2021-08-04 AU AU2021321433A patent/AU2021321433A1/en active Pending
- 2021-08-04 WO PCT/US2021/044564 patent/WO2022031862A2/en not_active Ceased
- 2021-08-04 JP JP2023507667A patent/JP2023536633A/ja active Pending
- 2021-08-04 KR KR1020237007667A patent/KR20230048523A/ko active Pending
- 2021-08-04 EP EP21854105.0A patent/EP4192468A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9994567B2 (en) | Synthesis of heterocyclic compounds | |
| RU2347778C2 (ru) | Новые антагонисты р2х7 рецепторов, способ их получения, фармацевтическая композиция, способ лечения и применение на их основе | |
| JP2024522174A5 (cg-RX-API-DMAC10.html) | ||
| JP2021530442A5 (cg-RX-API-DMAC10.html) | ||
| JP2020512272A5 (cg-RX-API-DMAC10.html) | ||
| CA2632194A1 (en) | N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases | |
| JP2011527686A5 (cg-RX-API-DMAC10.html) | ||
| JP2007511527A5 (cg-RX-API-DMAC10.html) | ||
| JP2011219498A5 (cg-RX-API-DMAC10.html) | ||
| JP2009542716A5 (cg-RX-API-DMAC10.html) | ||
| EA200600225A1 (ru) | Производные пиперазина для лечения вич инфекций | |
| JP2022525069A5 (cg-RX-API-DMAC10.html) | ||
| CA2011346A1 (en) | 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same | |
| RU2006102127A (ru) | Производные хинолина и их применение в терапии | |
| RU2007136535A (ru) | Пептидомиметические соединения и получение биологически активных производных | |
| JP2024520832A5 (cg-RX-API-DMAC10.html) | ||
| JP2024009799A5 (cg-RX-API-DMAC10.html) | ||
| JP2023538524A5 (cg-RX-API-DMAC10.html) | ||
| JP2017519796A5 (cg-RX-API-DMAC10.html) | ||
| JP2024545787A5 (cg-RX-API-DMAC10.html) | ||
| AU2014351354B2 (en) | Improved process for the preparation of pomalidomide and its purification | |
| JP2019527724A5 (cg-RX-API-DMAC10.html) | ||
| JP2020514299A5 (cg-RX-API-DMAC10.html) | ||
| ES2870476T3 (es) | Un proceso mejorado para la preparación de diclorhidrato de trientina | |
| RU2007148224A (ru) | Производные пиперидин-4-иламида и их применение в качестве антагонистов рецептора sst подтипа 5 |